Similar Articles
291 Massive bleeding from a gastric artery pseudoaneurysm in hepatocellular carcinoma treated with atezolizumab plus bevacizumab: A case report
292 Correction: Propensity-matched analysis of patients with intrahepatic cholangiocarcinoma or mixed hepatocellular-cholangiocarcinoma and hepatocellular carcinoma undergoing a liver transplant
293 Transcription factor glucocorticoid modulatory element-binding protein 1 promotes hepatocellular carcinoma progression by activating Yes-associate protein 1
294 Role of p53 suppression in the pathogenesis of hepatocellular carcinoma
295 Inflammation-related nomogram for predicting survival of patients with unresectable hepatocellular carcinoma received conversion therapy
296 Acute respiratory distress syndrome and severe pneumonitis after atezolizumab plus bevacizumab for hepatocellular carcinoma treatment: A case report
297 Current and novel approaches in the pharmacological treatment of hepatocellular carcinoma
298 Radiomic advances in the transarterial chemoembolization related therapy for hepatocellular carcinoma
299 Surgical treatment for recurrent hepatocellular carcinoma: Current status and challenges
300 Ablative strategies for recurrent hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA